CryoLife Announces Release Date And Teleconference Call Details For The Second Quarter 2003 Financial Results

July 22, 2003 at 11:49 AM EDT

ATLANTA, July 22 /PRNewswire-FirstCall/ -- CryoLife, Inc. (NYSE: CRY), a human tissue processing and medical device company, announced today that second quarter 2003 financial results will be released on Tuesday, August 5, 2003. The Company will hold a teleconference call and live webcast at 11:15 a.m. Eastern Time, August 5, 2003, to discuss second quarter results followed by a question and answer session hosted by Steven G. Anderson, CryoLife President and Chief Executive Officer.

To listen to the live teleconference please dial 973-339-3086 a few minutes prior to 11:15 a.m. No identification number is required. A replay of the teleconference will be available August 5 through August 8 and can be accessed by calling (toll free) 877-519-4471 or 973-341-3080. The identification number for the replay is 4061533.

The live webcast can be accessed by going to the Investor Relations section of the CryoLife web site at www.cryolife.com. A replay of the webcast will be available on the CryoLife web site until August 8.

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiovascular and vascular surgeries throughout the United States and Canada. The Company's BioGlue(R) Surgical Adhesive is FDA approved as an adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels and is CE marked in the European Community and approved in Canada for use in soft tissue repair and approved in Australia for use in vascular and pulmonary sealing and repair. The Company also manufactures the SynerGraft(R) Vascular Graft, which is CE marked for distribution within the European Community.

For additional information about the company, visit CryoLife's Web site: http://www.cryolife.com.

Media Contacts:
Joseph T. Schepers
Vice President, Corporate Communications
(770) 419-3355

Katie Brazel
Fleishman Hillard
(404) 739-0150

SOURCE CryoLife, Inc.